1	9 Have concomitant use of vigabatrin participants who took vigabatrin in the past must be off vigabatrin for approximately 5 months prior to Visit 1 and must have documentation showing no evidence of a vigabatrin-associated clinically significant abnormality in the visual perimetry test|vigabatrin[26,36]|||||||5 months[123,131]||C0048044|14851|14851|vigabatrin
1	9 Have concomitant use of vigabatrin participants who took vigabatrin in the past must be off vigabatrin for approximately 5 months prior to Visit 1 and must have documentation showing no evidence of a vigabatrin-associated clinically significant abnormality in the visual perimetry test|vigabatrin[59,69]|||||||||C0048044|14851|14851|vigabatrin
1	9 Have concomitant use of vigabatrin participants who took vigabatrin in the past must be off vigabatrin for approximately 5 months prior to Visit 1 and must have documentation showing no evidence of a vigabatrin-associated clinically significant abnormality in the visual perimetry test|vigabatrin[94,104]|||||||||C0048044|14851|14851|vigabatrin
1	9 Have concomitant use of vigabatrin participants who took vigabatrin in the past must be off vigabatrin for approximately 5 months prior to Visit 1 and must have documentation showing no evidence of a vigabatrin-associated clinically significant abnormality in the visual perimetry test|vigabatrin[202,212]|||||||||C0048044|14851|14851|vigabatrin
